The landscape of clinical trials in Sub-Saharan Africa (SSA) in 2026 is poised for transformative growth. Despite historically representing only a fraction of global research, less than 3% of worldwide trials, the region is emerging as a pivotal frontier in healthcare innovation. With a population exceeding 1.1 billion and bearing 25% of the global disease […]
What 2026 Holds for Clinical Trials in Sub-Saharan Africa Read More »
Nigeria, Africa’s most populous nation (approximately 235 million people), is finally turning the page on decades of health-sector dependency. Historically, we have imported approximately 70% of our drugs and virtually all vaccines. Patients often spend up to $2 billion a year travelling abroad for care. But today, a bold, government-led reset is underway. The new Presidential
Nigeria’s Healthcare Leap: A CRO’s Strategic Perspective Read More »
The statistics on sickle cell disease (SCD) are a stark reminder of a profound health disparity. The African continent shoulders approximately 80% of the global burden, with Nigeria alone accounting for an annual incidence of 150,000 newborns with the disease. This is a deeply indigenous challenge that has been met with a passive, and frankly,
Key Voices Charting a New Path for Sickle Cell Disease (SCD) in Africa Read More »
Every medical breakthrough, every lifesaving treatment, every public health victory began with one invisible step: A test. A vial of blood. A strand of DNA. A microscopic sample that tells us what the human eye cannot see. In the world’s strongest healthcare systems, laboratories are the silent engine. They catch diseases early, fuel drug discovery,
Introduction In clinical trials, the quest for equity, consistency, and global credibility hinges on one critical element: standardization. While funding, training, and infrastructure often dominate the conversation, Dr. Halima Bello-Manga highlights a more foundational change that can revolutionize clinical trials in Africa: the need for data standardization and thorough documentation. The Case for Standardized Practice in
Introduction Project management is more than a supporting function in clinical research; it is the engine that powers success. In today’s complex and highly regulated environment, effective project management turns intricate, multi-stakeholder trials into streamlined, compliant, and cost-efficient programs. With up to 12% of total clinical trial budgets lost to inefficiencies, applying structured planning and
The Role of Project Management in Clinical Research Success Read More »
Introduction Volunteering for a clinical trial is not only a way to help advance groundbreaking medical research, but it can also give you access to innovative treatments. In this comprehensive guide, we explain the clinical trial process, answer frequently asked questions, and show you how to become a clinical trial volunteer. Eligibility and Volunteer Requirements
How to Volunteer for a Clinical Trial: What You Need to Know Read More »
Imagine you are a seasoned investigator overseeing a multicenter trial for a novel cancer treatment, and during an inspection by regulatory authorities, they raise some concerns about inconsistencies in the patient records. One participant’s dosage history appears incomplete, leaving gaps that cannot be easily explained. Another participant’s adverse event report seems suspiciously altered, raising red
Audit Trails in Clinical Research: Ensuring Accountability and Transparency Read More »
Why Data Integrity in Clinical Trials Matters in Africa Data integrity in clinical trials has remained a hot topic in Africa, considering the upward trajectory of the region’s clinical trials sector. The growth in Africa’s clinical trial landscape is driven by unique demographic and genetic attributes, coupled with ongoing efforts to strengthen research infrastructure and
Data Integrity in Clinical Trials: Best Practices for Ensuring Reliable Results Read More »
Introduction Kidney diseases represent a significant and growing public health challenge worldwide, but the burden is particularly acute in sub-Saharan Africa (SSA). This region, characterized by limited healthcare infrastructure, widespread poverty, and a high prevalence of communicable and non-communicable diseases, faces unique challenges in addressing kidney diseases. However, these challenges also present opportunities for groundbreaking
